References:
1. McCutcheon RA, Reis Marques T, Howes, OD. Schizophrenia-an overview. JAMA psychiatry 2020; 77: 201–210.
2. Jauhar S, Johnstone M, McKenna PJ. Schizophrenia. Lancet 2022; 399: 473–486.
3. Leucht S, Siafis S, McGrath JJ, et al. Schizophrenia. Nat Rev Dis Primers 2025; 11: 83.
4. Jones HJ, Hammerton G, McCloud T, et al. Examining pathways between genetic liability for schizophrenia and patterns of tobacco and cannabis use in adolescence. Psychol Med 2022; 52: 132‒139.
5. Selten JP, Di Forti M, Quattrone D, et al. The contribution of cannabis use to the increased psychosis risk among minority ethnic groups in Europe. Psychol Med 2024; 54: 2937‒2946.
6. Laurens KR, Luo L, Matheson SL, et al. Common or distinct pathways to psychosis? A systematic review of evidence from prospective studies for developmental risk factors and antecedents of the schizophrenia spectrum disorders and affective psychoses. BMC Psychiatry 2015; 15: 205.
How do risk factors in the development of schizophrenia interact?
